In invasive carcinoma, CCL20 has been reported to be up-regulated in association with fenretinide therapy (2.03-fold) and antifolate treatment, suggesting a synergistic action between CCL20 and fenretinide and an inverse correlation with thymidylate synthetase (TS) [69,70,71]. The gene discussed is TYMS; the disease is invasive carcinoma.